Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Not Confirmed
Not Confirmed
29-31 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Industry Trade Show
Not Confirmed
29-31 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
22 Mar 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/fda-rejects-hengrui-elevars-pd-1-cancer-drug-combination-again
27 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/27/3015867/0/en/Elevar-Therapeutics-Announces-the-Formation-and-Members-of-Scientific-Advisory-Board.html
24 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/24/3014984/0/en/Elevar-Therapeutics-Presents-Results-from-Post-Hoc-Analysis-of-CARES-310-Study-Evaluating-the-Impact-of-Viral-and-Non-Viral-Etiology-on-Survival-in-Hepatocellular-Carcinoma.html
03 Dec 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/12/03/2990580/0/en/Elevar-Therapeutics-and-Relay-Therapeutics-Announce-Exclusive-Global-Licensing-Agreement-for-Lirafugratinib-in-FGFR2-Driven-Cholangiocarcinoma-and-Other-Solid-Tumors.html
03 Dec 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/relay-passes-baton-elevar-handing-nda-ready-rare-cancer-asset-500m
21 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/21/2966150/0/en/Elevar-Therapeutics-Announces-FDA-Acceptance-of-New-Drug-Application-Resubmission-for-Rivoceranib-in-Combination-with-Camrelizumab-as-a-First-line-Systemic-Treatment-for-Unresectab.html
ABOUT THIS PAGE